Mammalian maternal diabetes results in transient and localized alterations in glycation products, VEGF expression and Smad2 phosphorylation, overlapping with those regions of the developing heart that are most sensitive to diabetes-induced CHD [125]. The gene discussed is SMAD2; the disease is diabetes mellitus.